Quarterly report · Q3
4452.TEDINET S100PIT9
Period2022-01-01 → 2022-09-30
Filed2022-11-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.13T | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥393.8bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.42T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.02T | 2021-01-01 → 2021-09-30 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥345.8bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥76.9bn | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥23.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥109.0bn | 2021-01-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥38.4bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥85.1bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥24.6bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥150.0bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥113.5bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥39.4bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥58.3bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥19.4bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥109.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥82.1bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.5bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥59.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥19.7bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥83.4bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥29.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥1.73T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥1.70T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.63T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥724.8bn | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥720.1bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.01T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥983.9bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥929.9bn | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥938.2bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥984.5bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥965.1bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥912.4bn | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥240.0bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥336.1bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥299.0bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥353.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥73.2bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥175.5bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥121.3bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥58.7bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥67.2bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥50.2bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥136.8bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥141.6bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥135.7bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥123.82 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥41.65 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥230.59 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥172.42 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥62.32 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥123.82 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥41.65 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥230.57 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥172.4 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥62.32 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 56.8% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.9% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 16
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | ¥485m |
| jpcrp040300-q3r_E00883-000Chemical Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥26.8bn |
| jpcrp040300-q3r_E00883-000Consumer Products Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥49.6bn |
| jpcrp040300-q3r_E00883-000Cosmetics Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥3.4bn |
| jpcrp040300-q3r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥27.2bn |
| jpcrp040300-q3r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥18.9bn |
| jpcrp040300-q3r_E00883-000Life Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥24m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | ¥76.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-09-30 | ¥668m |
| jpcrp040300-q3r_E00883-000Chemical Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥23.3bn |
| jpcrp040300-q3r_E00883-000Consumer Products Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥85.0bn |
| jpcrp040300-q3r_E00883-000Cosmetics Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥97m |
| jpcrp040300-q3r_E00883-000Health And Beauty Care Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E00883-000Hygiene And Living Care Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥41.1bn |
| jpcrp040300-q3r_E00883-000Life Care Businessreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥2.5bn |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥108.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 845
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -51790000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -50031000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -67152000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -68151000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -802000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -419000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 795000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 2038000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -135693000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -136751000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YTDDuration | -64613000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYTDDuration | -122323000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 353176000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 336069000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 10404000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 26232000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 298967000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 239978000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 357171000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 261177000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 38115000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 165895000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 822358000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 198601000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1020959000000 | JPY |
| Sales to external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Sales to external customers IFRS | Prior1YTDDuration | 1020959000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | - | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 29357000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 29357000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -29357000000 | JPY |
| Intersegment sales IFRS | Prior1YTDDuration | - | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 357171000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 261177000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 38115000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 165895000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 822358000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ChemicalBusinessReportableSegmentMember | 227958000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1050316000000 | JPY |
| Net sales IFRS | Prior1YTDDuration_ReconcilingItemsMember | -29357000000 | JPY |
| Net sales IFRS | Prior1YTDDuration | 1020959000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HygieneAndLivingCareBusinessReportableSegmentMember | 41136000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000HealthAndBeautyCareBusinessReportableSegmentMember | 41318000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000LifeCareBusinessReportableSegmentMember | 2471000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000CosmeticsBusinessReportableSegmentMember | 97000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E00883-000ConsumerProductsBusinessReportableSegmentMember | 85022000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |